Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
about
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase II Study of Subcutaneous ...... Neuroendocrine Tumours (NETs)
@en
Phase II Study of Subcutaneous ...... aly and Neuroendocrine Tumours
@nl
type
label
Phase II Study of Subcutaneous ...... Neuroendocrine Tumours (NETs)
@en
Phase II Study of Subcutaneous ...... aly and Neuroendocrine Tumours
@nl
prefLabel
Phase II Study of Subcutaneous ...... Neuroendocrine Tumours (NETs)
@en
Phase II Study of Subcutaneous ...... aly and Neuroendocrine Tumours
@nl
P17
P1050
P1476
A Phase II, Open-label, Multic ...... Treated With Sandostatin® LAR®
@en
P3098
NCT02299089
P580
2015-01-01T00:00:00Z
P582
2016-05-01T00:00:00Z